The content on this site is intended for healthcare professionals only

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

For the latest ecancer COVID-19 resources, click on this link

Why do men face a higher risk of most types of cancer than women?

Why do men face a higher risk of most types of cancer than women?

Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lung cancer deaths

Budget impact analysis demonstrates NELSON screening model would save more than 18,000 premature lun...

FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer

FDA approves fam-trastuzumab deruxtecan-nxki for HER2-low breast cancer

FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer

FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer

WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advanced NSCLC: DOLPHIN Study

WCLC 2022: Phase II study of durvalumab plus concurrent radiotherapy in unresectable locally advance...

WCLC 2022: Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy

WCLC 2022: Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy

WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs best supportive care in resected NSCLC

WCLC 2022: IMPower010: Overall survival interim analysis of a phase III study of atezolizumab vs bes...

WCLC 2022: NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients with resectable non-small cell lung cancer

WCLC 2022: NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients w...

WCLC 2022: Increased utilization of stereotactic body radiotherapy has decreased treatment disparities for early-stage NSCLC

WCLC 2022: Increased utilization of stereotactic body radiotherapy has decreased treatment dispariti...

WCLC 2022: Younger patients with NSCLC significantly more likely to be diagnosed with later stages of the disease than older patients

WCLC 2022: Younger patients with NSCLC significantly more likely to be diagnosed with later stages o...

Tweets by @ecancer

More from ecancer